Full text is available at the source.
Comparison of endoscopic sleeve gastroplasty versus surgical sleeve gastrectomy: a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database analysis
Comparing less invasive and surgical stomach sleeve procedures using a weight loss surgery database
AI simplified
Abstract
Among 6,054 patients undergoing endoscopic sleeve gastroplasty (ESG), 3.8% experienced readmissions within 30 days.
- Adverse events were low for both ESG and sleeve gastrectomy (SG), with major adverse events occurring in 1.1% of SG patients and 1.4% of ESG patients.
- Patients undergoing ESG had higher rates of readmissions (3.8% vs 2.6%), reoperations (1.4% vs 0.8%), and reinterventions (2.8% vs 0.7%) compared to those undergoing SG.
- Race did not significantly affect the occurrence of adverse events after ESG.
- However, black patients were associated with a higher risk of adverse events after SG.
AI simplified